Regeneron Pharmaceuticals reported $3.03B in Current Liabilities for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Agenus AGEN:US $ 163.06M 6.12M
Agios Pharmaceuticals AGIO:US $ 48.4M 2.6M
Alimera Sciences ALIM:US $ 25.43M 8.43M
Alnylam Pharmaceuticals ALNY:US $ 657.68M 51.72M
Amgen AMGN:US $ 12618M 268M
Astellas Pharma 4503:JP Y 740538M 53127M
AstraZeneca AZN:LN 21815M 925M
Biogen BIIB:US $ 5018M 1071.4M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Bluebird Bio BLUE:US $ 148.86M 5.97M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Esperion Therapeutics ESPR:US $ 82.28M 3.19M
Gilead Sciences GILD:US $ 9220M 662M
GlaxoSmithKline GSK:LN 37835M 13557M
Intercept Pharmaceuticals ICPT:US $ 151.43M 0.39M
IONIS PHARMACEUT IONS:US $ 228.45M 12.1M
Kyowa Hakko Kirin 4151:JP Y 103507M 13040M
Moderna Inc MRNA:US 6.81B 2.43B
Neurocrine Biosciences NBIX:US $ 285.7M 32.2M
Novartis NVS:US $ 27646M 2161M
Novartis NOVN:VX SF 27646M 2161M
Ophthotech OPHT:US $ 26.48M 7.31M
Opthea Ltd OPT:AU 8.92M 5.82M
Puma Biotechnology PBYI:US $ 56.83M 17.95M
Regeneron Pharmaceuticals REGN:US $ 3033.9M 26.3M
Sarepta Therapeutics SRPT:US $ 545.57M 90.6M
Seattle Genetics SGEN:US $ 608.52M 77.23M
Teva Pharmaceutical TEVA:IT 11B 617M
Ultragenyx Pharmaceutical RARE:US $ 220.64M 53.4M
United Therapeutics UTHR:US $ 331.5M 38.9M
Vertex Pharmaceuticals VRTX:US $ 2556.2M 376M
YTE INCY:US $ 926.67M 40.51M